transcripts Archives - Page 2 of 6 - Esquire Deposition Solutions

I won the lottery. Does anyone have to know?

By Esquire Deposition Solutions | March 20, 2018

Three intriguing new cases related to privacy, legal and personal, just cropped up: A court deals another blow to Facebook’s face-recognition program. A landowner fights to keep spy cameras and border patrollers off his ranch. And a lottery winner tries to stay anonymous. Lottery winner won’t identify herself Can you blame the lottery winner? She…

What’s next in malpractice litigation?

By Esquire Deposition Solutions | March 9, 2018

Malpractice litigation isn’t what it used to be. Successful medical malpractice claims have been falling in number over recent decades. The trend could shift, however, if litigators gravitate toward new, tech-related frontiers of the practice.

Weed and robots to alter liability landscape

By Esquire Deposition Solutions | March 1, 2018

Sale of recreational cannabis is legal in a handful of states with more expected to follow, raising new product liability questions for sellers, regulators, insurers, and litigators. For instance, should cannabis be treated like liquor or be considered an unreasonably dangerous product?

When graffiti is art, whitewash is a weapon

By Esquire Deposition Solutions | February 21, 2018

Plaintiff attorneys: you might want to reconsider your definition of art.

Defense attorneys: be careful what your clients demolish, and how they demolish it.

Artists: your community just got bigger.

Why secrecy matters in product liability

By Esquire Deposition Solutions | February 15, 2018

Confidentiality may be a non-negotiable condition for a victim to secure a settlement, so granting it may be your first job if you’re a plaintiff attorney. And confidentiality clearly protects manufacturers’ reputations, so obtaining a protective order may be your first job as a defense attorney.

Can litigation halt the opioid crisis?

By Esquire Deposition Solutions | February 8, 2018

Numerous claims have been filed across the country by cities (including New York), counties and states against makers and distributors of prescription painkillers. Delaware, for example, just became at least the 15th state to sue, according to Reuters. The lawsuit, filed in a state court, targets a number of drug makers, distributors and retailers.